Moteur de recherche d’entreprises européennes
Financement de l’UE (3 296 000 €) : Réseau d’infrastructure de recherche clinique pédiatrique Hor 19/12/2016 Programme de recherche et d'innovation de l'UE « Horizon »
Texte
Réseau d’infrastructure de recherche clinique pédiatrique
Children’s health is a major societal challenge for Europe and the world, requiring development of paediatric medicines and treatments strategies based on evidence derived from clinical trials demonstrating efficacy and safety in infants and children, rather than on uncritical extrapolation from adult data (over 50 % of the medicines used for children had not been tested in this specific age group). Conducting clinical trials in children requires specific competences and infrastructure. ECRIN-ERIC (www.ecrin.org) is a generic infrastructure for multinational trial management, in any disease area. However it does not specifically address the paediatric needs in terms of trial management capacity. In its 2016 Roadmap, ESFRI suggested an upgrade of ECRIN to develop a common infrastructure for paediatric trial management through cooperation with the European Paediatric Clinical Trial Research Infrastructure (EPCTRI). The resulting PedCRIN project is also a unique opportunity to improve ECRIN business model and financial sustainability, attracting more industry-sponsored trials and more Member and Observer countries. PedCRIN builds on five work packages : project coordination (WP1); establishment of a strategy and upgrade of the governance and business plan, through a Sustainability Board jointly involving the scientific partners and the government representatives (WP2); development of tools specific for paediatric and neonatal trials (WP3) (methodology, outcome measures, adverse event reporting, bio-sample management, ethical and regulatory database, monitoring, quality and certification); operational support provided as transnational access to a few pilot trials to test the updated organisation and tools (WP4); communication targeting user’s communities (including industry), policymakers, patient and parents’ empowerment (WP5). Two other ESFRI-landmarks, BBMRI-ERIC and EATRIS ERIC, will contribute to PedCRIN.
| Aibili Associação para Investigacao Biomedica e Innovacao em Luz e Imagem | 0,00 € |
| Aristotelio Panepistimio Thessalonikis | 48 750 € |
| Consorzio Per Valutazioni Biologiche E Farmacologiche | 170 625 € |
| Ecrin European Clinical Research Infrastructure Network | 1 530 125 € |
| Fundacio Privada Per A La Recerca i La Docencia Sant Joan de Deu | 196 875 € |
| Helse Bergen HF | 48 750 € |
| HUS-Yhtyma | 178 125 € |
| Institut National de la Sante et de la Recherche Medicale | 189 375 € |
| Istituto Superiore Di Sanita | 0,00 € |
| Karolinska Institutet | 48 750 € |
| Luxembourg Institute OF Health | 0,00 € |
| Masarykova Univerzita | 0,00 € |
| Okids GmbH | 48 750 € |
| Stichting Radboud Universitair Medisch Centrum | 22 500 € |
| Stichting Radboud Universiteit | 155 625 € |
| ST Olavs Hospital HF | 0,00 € |
| Swiss Clinical Trial Organisation (Scto) | 48 750 € |
| Tartu Ulikool | 48 750 € |
| The National Children's Research Centre | 48 750 € |
| The University of Liverpool | 325 875 € |
| Universidade Nova de Lisboa | 0,00 € |
| Vereniging Samenwerkende Ouder- EN Patientenorganisaties | 185 625 € |
https://cordis.europa.eu/project/id/731046
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.